Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study-Reference-Cited by-同舟云学术

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

Published:2010-12 Issue:3 Volume:43 Page:299-303
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Rubia Javier de la,Moscardó Federico,Gómez María J,Guardia Ramón,Rodríguez Pilar,Sebrango Ana,Zamora Concepción,Debén Guillermo,Goterris Rosa,López Rafaela,Peña Francisco,Pujol Misericordia,Vidaller Antonio,Río-Garma Julio del,Sanz Miguel A.

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Thrombotic thrombocytopenic purpura;George;New Engl J Med,2006

2. Journey in reverse: TTP from bedside to blood bank to bench;Moake;J Clin Apher,2007

3. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group;Rock;N Engl J Med,1991

4. Thrombotic thrombocytopenic purpura treatment in year 2000;Rock;Haematologica,2000

5. Thrombotic thrombocytopenic purpura and its diagnosis;Veyradier;J Thromb Haem,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of CBL-CIPK signaling networks and their response to abiotic stress in sugarcane;International Journal of Biological Macromolecules;2024-10

2. Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura;BLOOD TRANSFUS-ITALY;2023

3. Global Health Resource Utilization and Cost-Effectiveness of Therapeutics and Diagnostics in Immune Thrombotic Thrombocytopenic Purpura (TTP);Journal of Clinical Medicine;2023-07-25

4. Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments;Transfusion and Apheresis Science;2023-06

5. Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura;Expert Review of Hematology;2021-08-03